Contact
Please use this form to send email to PR contact of this press release:
Curium Announces Plan to Submit an Application to Market Generic Ioflupane I 123 Injection in the U.S.
TO:
Please use this form to send email to PR contact of this press release:
Curium Announces Plan to Submit an Application to Market Generic Ioflupane I 123 Injection in the U.S.
TO: